Key statistics
On Friday, LivaNova PLC (LIVN:NSQ) closed at 65.80, -3.12% below its 52-week high of 67.92, set on Feb 02, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 64.16 |
|---|---|
| High | 66.61 |
| Low | 63.58 |
| Bid | 26.28 |
| Offer | 67.42 |
| Previous close | 63.91 |
| Average volume | 684.88k |
|---|---|
| Shares outstanding | 54.61m |
| Free float | 54.41m |
| P/E (TTM) | -- |
| Market cap | 3.59bn USD |
| EPS (TTM) | -4.01 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Press releases
- LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results
- LivaNova to Present at J.P. Morgan Healthcare Conference in January
- LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting
- LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea
- LivaNova to Present at Piper Sandler Healthcare Conference in December
- LivaNova’s VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services
More ▼
